The complement system in the pathogenesis of antineutrophil cytoplasm antibodies-associated vasculitis;El sistema del complemento en la patogenia de las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilo

Reumatologia Clinica

Volumn 7, Issue SUPPL. 3, 2011, Pages

  Flores Suárez, Luis F ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Animal models; Antineutrophil cytoplasm autoantibodies; Complement

Indexed keywords

ANCA ASSOCIATED VASCULITIS; ARTICLE; BLOOD VESSEL BIOPSY; COMPLEMENT SYSTEM; DISEASE MODEL; HUMAN; NONHUMAN;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; AUTOANTIGENS; BIOPSY; COMPLEMENT ACTIVATION; COMPLEMENT C5; COMPLEMENT C5A; COMPLEMENT SYSTEM PROTEINS; DNA-BINDING PROTEINS; HUMANS; KIDNEY; MICE; MICE, INBRED C57BL; MICROSCOPIC POLYANGIITIS; MYELOBLASTIN; PEROXIDASE; WEGENER GRANULOMATOSIS;

EID: 83255167079     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2011.09.002     Document Type: Article

References (12)

1. Chen M., Daha M.R., Kallenberg C.G.M. The complement system in systemic autoimmune disease. J Autoimmun 2010, 34:J276-J286.
2. Xiao H., Heeringa P., Hu P., Liu Z., Zhao M., Aratani Y., et al. Antineutrophil cytoplasmic autonatibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002, 110:965-973.
3. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitis: proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
4. Ronco P., Verroust P., Mignon F., Kourilsky O., Vanhille P., Meyrier A., et al. Immunopathologic studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies. QJM 1983, 52:212-223.
5. Haas M., Eustace J.A. Immune complex depostis in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004, 65:2145-2152.
6. Chen M., Xing G.Q., Yu F., Liu G., Zhao M.H. Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 2009, 24:1247-1252.
7. Hu C.H., O'Loughlin S., Winkelmann R.K. Cutaneous manifestations of Wegener granulomatosis. Arch Dermatol 1977, 133:175-182.
8. Brons R.H., De Jong M.C.J.M., De Boer N.K., Stegeman C.A., Kallenberg C.G.M., Cohen Tervaert J.W. Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis 2001, 60:1097-1102.
9. Xiao H., Schreiber A., Heeringa P., Falk R.J., Jennette J.C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 2007, 170:52-64.
10. Xing G.Q., Chen M., Liu G., Heeringa P., Zhang J.J., Zheng X., et al. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-inmmune vasculitis. J Clin Immunol 2009, 29:282-291.
11. Schreiber A., Xiao H., Jennette J.C., Schneider W., Luft F.C., Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 2009, 20:289-298.
12. Woodruff T.M., Nandakumar K.S., Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol 2011, 48:1631-1642.